HJURP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.550600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.269000E-01
Normal-vs-Stage2
2.083200E-01
Normal-vs-Stage3
6.634000E-01
Normal-vs-Stage4
4.908400E-01
Stage1-vs-Stage2
2.487200E-01
Stage1-vs-Stage3
9.834000E-01
Stage1-vs-Stage4
7.352600E-01
Stage2-vs-Stage3
3.560000E-01
Stage2-vs-Stage4
5.561400E-01
Stage3-vs-Stage4
7.893000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.609200E-01
Normal-vs-AfricanAmerican
5.097000E-01
Normal-vs-Asian
8.771700E-02
Caucasian-vs-AfricanAmerican
4.037200E-01
Caucasian-vs-Asian
5.210800E-01
AfricanAmerican-vs-Asian
1.503350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.378600E-01
Normal-vs-Female
2.863400E-01
Male-vs-Female
9.692800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.958600E-01
Normal-vs-Age(41-60Yrs)
2.488400E-01
Normal-vs-Age(61-80Yrs)
2.449600E-01
Normal-vs-Age(81-100Yrs)
2.446000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.533030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.195200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.490040E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.886040E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.820600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.887000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.611800E-01
Normal-vs-Daily Drinker
2.546800E-01
Normal-vs-Weekly Drinker
2.003000E-01
Normal-vs-Occasional Drinker
2.185000E-01
Normal-vs-Social Drinker
2.535400E-01
Non Drinker-vs-Daily Drinker
6.451800E-01
Non Drinker-vs-Weekly Drinker
8.954200E-01
Non Drinker-vs-Occasional Drinker
3.968200E-01
Non Drinker-vs-Social Drinker
9.128800E-01
Daily Drinker-vs-Weekly Drinker
5.247800E-01
Daily Drinker-vs-Occasional Drinker
2.063600E-01
Daily Drinker-vs-Social Drinker
5.602200E-01
Weekly Drinker-vs-Occasional Drinker
5.057400E-01
Weekly Drinker-vs-Social Drinker
9.815200E-01
Occasional Drinker-vs-Social Drinker
4.973800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.601800E-01
Normal-vs-Grade 2
8.477000E-01
Normal-vs-Grade 3
8.433800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.236400E-04
Grade 1-vs-Grade 3
5.65270000000284E-05
Grade 1-vs-Grade 4
6.601800E-01
Grade 2-vs-Grade 3
1.661020E-01
Grade 2-vs-Grade 4
8.477000E-01
Grade 3-vs-Grade 4
8.433800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.866400E-01
Normal-vs-NonDiabetic
2.275400E-01
Diabetic-vs-NonDiabetic
1.651760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.620000E-02
Normal-vs-NoPancreatitis
2.901200E-01
Pancreatitis-vs-NoPancreatitis
3.882200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.452800E-01
Normal-vs-N1
2.411800E-01
N0-vs-N1
4.118000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.585690E-02
Normal-vs-TP53-NonMutant
3.744800E-01
TP53-Mutant-vs-TP53-NonMutant
5.44870037977319E-10
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
